World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 13 November 2023
Main ID:  NCT02246387
Date of registration: 11/09/2014
Prospective Registration: Yes
Primary sponsor: Oslo University Hospital
Public title: Follow-up Study After Manchester Operation for Pelvic Organ Prolapse MAP-POP
Scientific title: Does the Manchester Operation for Pelvic Organ Prolapse Give Sufficient Apical Fixation?
Date of first enrolment: October 2014
Target sample size: 209
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02246387
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Norway
Contacts
Name:     Rune Svenningsen, PhD
Address: 
Telephone:
Email:
Affiliation:  Oslo University Hospital; University of Oslo
Name:     Anne C Staff, PhD
Address: 
Telephone:
Email:
Affiliation:  Oslo University Hospital; University of Oslo
Name:     Sissel H Oversand, MD
Address: 
Telephone:
Email:
Affiliation:  Oslo University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Women aged = 18 years, understanding and reading Scandinavian or English language and
being able to sign an informed consent. Non- Scandinavian speakers can be enrolled in
the study as long as they understand and can communicate in English or Norwegian.

- Subjective distress from pelvic organ prolapse

- Cystocele Stage I - III with descent of the cervix Stage I-III, with or without a
defect of the posterior wall (rectocele, enterocele, hypotrophic perineum).

Exclusion Criteria:

- Previous total hysterectomy (including removal of the cervix and the cardinal
ligaments) or previous subtotal hysterectomy (removal of copus uteri).

- Previous surgery for POP

- Patients with a true Uterine prolapse with a descent of the corpus uteri stage II-III
and not just an elongated cervix, as this group may benefit from other procedures than
a Manchester operation (vaginal hysterectomy and sacrospinous fixation)

- Unable to understand patient information (in Norwegian or English) and sign an
informed consent.

- Patients in whom a colpocleisis (closing of the vagina) is deemed the better surgical
treatment, such as in elderly women not sexually active and not interested in future
vaginal intercourse.



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Pelvic Organ Prolapse
Intervention(s)
Procedure: Manchester Operation
Primary Outcome(s)
Percentage with POP-Q point C equal to or less than -5 at the 1 and 5 year postoperative control compared to preoperative findings for the whole population vs subgroup with levator avulsions. [Time Frame: Up to 7 years]
Changes in point C and D at the 1 and 5 year postoperative control compared to preoperative findings for the whole population vs subgroup with levator avulsions. [Time Frame: Up to 7 years]
Secondary Outcome(s)
Changes in dyspareunia between the preoperative evaluation and at the 1 and 5 year postoperative control (whole population vs subgroup with levator avulsions). [Time Frame: Up to 7 years]
Subjective satisfaction at the 1 and 5 year postoperative control (whole population vs subgroup with levator avulsions). [Time Frame: Up to 7 years]
De novo urinary incontinence at the 1 and 5 year postoperative control (whole population vs subgroup with levator avulsions). [Time Frame: Up to 7 years]
Secondary ID(s)
2013/2093/REK
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history